Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Collaboration revenue	$ 532	$ 410
Operating expenses:
Research and development	18,238	12,596
General and administrative	5,818	5,127
Total operating expenses	24,056	17,723
Loss from operations	(23,524)	(17,313)
Other income:
Interest income	1,086	1,072
Total other income	1,086	1,072
Loss before income tax expense	(22,438)	(16,241)
Income tax expense	(14)	(14)
Net loss	(22,452)	(16,255)
Unrealized holding loss on short-term investments, net of tax	(8)	(22)
Comprehensive loss	$ (22,460)	$ (16,277)
Net loss per share attributable to common stockholders- basic	$ (0.35)	$ (0.44)
Net loss per share attributable to common stockholders- diluted	$ (0.35)	$ (0.44)
Weighted-average common shares outstanding-basic	64,011,360	36,832,747
Weighted-average common shares outstanding-diluted	64,011,360	36,832,747